Your browser doesn't support javascript.
loading
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Lopes, Renato D; Higano, Celestia S; Slovin, Susan F; Nelson, Adam J; Bigelow, Robert; Sørensen, Per S; Melloni, Chiara; Goodman, Shaun G; Evans, Christopher P; Nilsson, Jan; Bhatt, Deepak L; Clarke, Noel W; Olesen, Tine K; Doyle-Olsen, Belinda T; Kristensen, Henriette; Arney, Lauren; Roe, Matthew T; Alexander, John H.
Afiliação
  • Lopes RD; Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (R.D.L., A.J.N., C.M., L.A., M.T.R., J.H.A.).
  • Higano CS; Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle (C.S.H.).
  • Slovin SF; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY (S.F.S.).
  • Nelson AJ; Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (R.D.L., A.J.N., C.M., L.A., M.T.R., J.H.A.).
  • Sørensen PS; Ferring Pharmaceuticals A/S, Copenhagen, Denmark (P.S.S., T.K.O., B.T.D.-O., H.K.).
  • Melloni C; Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (R.D.L., A.J.N., C.M., L.A., M.T.R., J.H.A.).
  • Goodman SG; IQVIA, Durham, NC (C.M.).
  • Evans CP; Division of Cardiology, St. Michael's Hospital, Department of Medicine, University of Toronto, Ontario, Canada (S.G.G.).
  • Nilsson J; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (S.G.G.).
  • Bhatt DL; Department of Urologic Surgery, University of California, Davis, Sacramento (C.P.E.).
  • Clarke NW; Department of Clinical Sciences Malmö, Lund University, Sweden (J.N.).
  • Olesen TK; Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
  • Doyle-Olsen BT; Department of Urology, The Christie and Salford Royal Hospitals Manchester, United Kingdom (N.W.C.).
  • Kristensen H; Ferring Pharmaceuticals A/S, Copenhagen, Denmark (P.S.S., T.K.O., B.T.D.-O., H.K.).
  • Arney L; Ferring Pharmaceuticals A/S, Copenhagen, Denmark (P.S.S., T.K.O., B.T.D.-O., H.K.).
  • Roe MT; Ferring Pharmaceuticals A/S, Copenhagen, Denmark (P.S.S., T.K.O., B.T.D.-O., H.K.).
  • Alexander JH; Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (R.D.L., A.J.N., C.M., L.A., M.T.R., J.H.A.).
Circulation ; 144(16): 1295-1307, 2021 10 19.
Article em En | MEDLINE | ID: mdl-34459214
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias da Próstata / Leuprolida Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Humans / Male Idioma: En Revista: Circulation Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias da Próstata / Leuprolida Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Humans / Male Idioma: En Revista: Circulation Ano de publicação: 2021 Tipo de documento: Article